D-269-2013 Class III Terminated
FDA drug recall D-269-2013 was initiated by Mylan Pharmaceuticals Inc. on Feb 26, 2013 and is designated Class III. Reason for recall: Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets.. The recall status is terminated (terminated Dec 5, 2013). Affected quantity: 2,405 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 1, 2013
- Initiation Date
- Feb 26, 2013
- Termination Date
- Dec 5, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,405 bottles
Product description
Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles, Manufactured for: Mylan Pharmaceuticals Inc ,Morgantown, WV 26505 U.S.A. Made in India; NDC 0378-20740-10
Reason for recall
Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets..
Distribution pattern
Nationwide.
Code information
Lot# 3002450; exp 8/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-269-2013
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026